Sika Interplant

  • Market Cap: Small Cap
  • Industry: Aerospace & Defense
  • ISIN: INE438E01032
  • NSEID:
  • BSEID: 523606
INR
902.00
-1.25 (-0.14%)
BSENSE

Mar 25

BSE+NSE Vol: 21.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

21.16 k (4.40%) Volume

Shareholding (Dec 2025)

FII

3.14%

Held by 3 FIIs

DII

0.04%

Held by 0 DIIs

Promoter

71.72%

how big is Sika Interplant?

06-Jun-2025

As of October 2023, Sika Interplant Systems Ltd has a market capitalization of 2,786.22 Cr, with net sales of 147.66 Cr and net profit of 26.53 Cr over the latest four quarters. Shareholder's funds are valued at 103.11 Cr, and total assets amount to 121.74 Cr.

Market Cap: Sika Interplant Systems Ltd has a market capitalization of 2,786.22 Cr, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 147.66 Cr, and the sum of Net Profit for the latest 4 quarters is 26.53 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in March 2024. The Shareholder's Funds are valued at 103.11 Cr, and the Total Assets amount to 121.74 Cr.

View full answer

Who are in the management team of Sika Interplant?

06-Jun-2025

As of March 2022, the management team of Sika Interplant includes Rajeev Sikka (Executive Chairman), Kunal Sikka (Managing Director & CEO), Anuradha Sikka (Director), and Sriee Aneetha M (Company Secretary). The Board also features independent directors C G Krishnadas Nair, R N Chawhan, S Santhanam, and Garimella Bhaskar Venkata Satya.

As of March 2022, the management team of Sika Interplant includes the following individuals:<BR><BR>1. Rajeev Sikka - Executive Chairman & Whole Time Director<BR>2. Kunal Sikka - Managing Director & CEO<BR>3. Anuradha Sikka - Director<BR>4. Sriee Aneetha M - Company Secretary & Compliance Officer<BR><BR>Additionally, the Board of Directors features several independent directors: <BR>- C G Krishnadas Nair<BR>- R N Chawhan<BR>- S Santhanam<BR>- Garimella Bhaskar Venkata Satya<BR><BR>These members contribute to the governance and strategic direction of the company.

View full answer

What does Sika Interplant do?

06-Jun-2025

Sika Interplant Systems Ltd is an engineering company specializing in the Aerospace, Defence & Space and Automotive sectors, with recent net sales of 46 Cr and a net profit of 8 Cr for the quarter ending March 2025. It has a market cap of Rs 2,826 Cr and key metrics include a P/E of 108.00 and a return on equity of 21.41%.

Overview: <BR>Sika Interplant Systems Ltd is an engineering-driven company focused on the Aerospace, Defence & Space (A&D) and Automotive sectors, categorized as a Small Cap in the Aerospace & Defense industry.<BR><BR>History: <BR>Sika Interplant Systems Ltd was incorporated in 1985 and has been actively involved in its sectors since then. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 46 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 8 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 2,826 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 108.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.15% <BR>Debt-Equity: -0.20 <BR>Return on Equity: 21.41% <BR>Price to Book: 23.10 <BR><BR>Contact Details: <BR>Address: No 3 Gangadhara Chetty Road, Bangalore Karnataka: 560042 <BR>Tel: 91-080-25599144/25599086 <BR>Email: comp.sec@sikaglobal.com <BR>Website: http://www.sikaglobal.com

View full answer

Has Sika Interplant declared dividend?

06-Jun-2025

Sika Interplant Systems Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of September 6, 2024. The company has shown impressive total returns, including 3971.6% over the last 5 years.

Sika Interplant Systems Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10 per share<BR>- Ex-date: 06 Sep 24<BR><BR>Dividend Yield: 0.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 172.96%, with no dividend return, resulting in a total return of 172.96%.<BR><BR>Over the past year, the price return was 180.58%, with a dividend return of 1.86%, leading to a total return of 182.44%.<BR><BR>In the 2-year period, the price return was 1056.22%, accompanied by a dividend return of 11.14%, culminating in a total return of 1067.36%.<BR><BR>For the 3-year period, the price return was 950.54%, with a dividend return of 13.87%, resulting in a total return of 964.41%.<BR><BR>In the 4-year period, the price return was 1806.9%, with a dividend return of 30.05%, leading to a total return of 1836.95%.<BR><BR>Over the last 5 years, the price return was 3896.26%, with a dividend return of 75.34%, resulting in a total return of 3971.6%.<BR><BR>Overall, Sika Interplant has declared a significant dividend while also achieving impressive total returns across multiple periods, indicating strong financial performance and shareholder value enhancement.

View full answer

Who are the peers of the Sika Interplant?

03-Jun-2025

Sika Interplant's peers include Hind.Aeronautics, Bharat Electron, Mazagon Dock, and others, with varying management risks and growth rates. Mazagon Dock leads in 1-year returns at 111.91%, while Sika Interplant has a return of 80.58%.

Peers: The peers of Sika Interplant are Hind.Aeronautics, Bharat Electron, Mazagon Dock, Bharat Dynamics, Cochin Shipyard, Rossell Techsys, CFF Fluid, Taneja Aerospace, Swan Defence, and Krishna Defence.<BR><BR>Quality Snapshot: Excellent management risk is observed at Hind.Aeronautics, Bharat Electron, and Mazagon Dock, while Good management risk is found at Bharat Dynamics and Cochin Shipyard. Average management risk is present at Sika Interplant, CFF Fluid, Taneja Aerospace, and Krishna Defence, whereas Below Average management risk is noted at Rossell Techsys and Swan Defence. In terms of Growth, Excellent growth is seen at Hind.Aeronautics, Bharat Electron, and CFF Fluid, while Average growth is found at Sika Interplant, and Below Average growth is noted at Bharat Dynamics, Cochin Shipyard, Rossell Techsys, Taneja Aerospace, and Swan Defence. Lastly, Excellent capital structure is observed at Hind.Aeronautics, Bharat Electron, Mazagon Dock, Bharat Dynamics, Cochin Shipyard, and Taneja Aerospace, while Average capital structure is found at CFF Fluid and Krishna Defence, and Below Average capital structure is noted at Rossell Techsys and Swan Defence.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mazagon Dock at 111.91%, while the peer with the lowest is Rossell Techsys, which has no recorded return. Sika Interplant's 1-year return of 80.58% is lower than that of Mazagon Dock but higher than Rossell Techsys. Additionally, Rossell Techsys, Taneja Aerospace, and Swan Defence have negative six-month returns.

View full answer

Is Sika Interplant overvalued or undervalued?

09-Jun-2025

As of June 30, 2023, Sika Interplant is considered very expensive and overvalued, with a PE ratio of 104.25 and significant premiums compared to peers, despite a strong year-to-date stock return of 135.13%.

As of 30 June 2023, the valuation grade for Sika Interplant moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued based on its high valuation ratios, including a PE ratio of 104.25, an EV to EBITDA ratio of 95.06, and a Price to Book Value of 22.32. These figures suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Sika Interplant's valuation stands out as particularly high, with Rail Vikas at a PE of 69.76 and Tube Investments at 87.5, both of which are also classified as very expensive. Additionally, the company has demonstrated strong returns, with a year-to-date stock return of 135.13% compared to the Sensex's 5.58%, further emphasizing the disparity between its performance and valuation metrics. Overall, Sika Interplant is deemed overvalued in the current market environment.

View full answer

Who are the top shareholders of the Sika Interplant?

17-Jul-2025

The top shareholders of Sika Interplant are Ultraweld Engineers LLP with 70.1%, followed by Rimo Capital Fund LP at 2.8%. Individual investors hold 21.44%, while two foreign institutional investors collectively own 3.11%, and mutual funds hold no shares.

The top shareholders of Sika Interplant include Ultraweld Engineers LLP, which holds the largest stake at 70.1%. Additionally, Rimo Capital Fund LP is the highest public shareholder with a 2.8% holding. The company also has 21.44% of its shares held by individual investors. There are two foreign institutional investors (FIIs) that collectively hold 3.11%, while mutual funds do not hold any shares in the company.

View full answer

Is Sika Interplant technically bullish or bearish?

07-Oct-2025

As of October 6, 2025, the trend is mildly bullish due to daily moving averages, but caution is advised as weekly indicators show mild bearishness and monthly RSI indicates potential weakness.

As of 6 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The monthly MACD remains bullish, providing a stronger long-term outlook. The RSI on the monthly is bearish, indicating potential weakness. Overall, while there are mixed signals, the daily indicators support a mildly bullish perspective.

View full answer

How has been the historical performance of Sika Interplant?

06-Nov-2025

Sika Interplant has shown significant growth, with net sales increasing from 106.03 crore in March 2024 to 147.66 crore in March 2025, and operating profit rising to 34.84 crore. Total assets and liabilities both reached 151.65 crore, reflecting balanced growth, while cash flow from operating activities decreased to 7.00 crore.

Answer:<BR>The historical performance of Sika Interplant shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 147.66 crore, a substantial increase from 106.03 crore in March 2024 and 60.01 crore in March 2023. The total operating income followed a similar upward trend, reaching 147.66 crore in March 2025 compared to 106.03 crore in the previous year. The company's operating profit (PBDIT) also saw a notable rise, climbing to 34.84 crore in March 2025 from 25.27 crore in March 2024. Profit before tax reached 33.08 crore, while profit after tax was recorded at 25.34 crore for the same period. <BR><BR>In terms of expenses, raw material costs increased to 107.58 crore in March 2025, reflecting the growing scale of operations. Total expenditure, excluding depreciation, was 118.84 crore, up from 86.13 crore in March 2024. The company's total assets rose to 151.65 crore, with total liabilities also increasing to 151.65 crore, indicating a balanced growth in both assets and liabilities. Cash flow from operating activities was reported at 7.00 crore, down from 19.00 crore in the previous year, while cash flow from investing activities showed a negative figure of -3.00 crore. Overall, Sika Interplant's financial performance demonstrates a robust growth trajectory, marked by increasing sales, profits, and asset values.<BR><BR>Breakdown:<BR>Sika Interplant's financial metrics reveal a strong growth trajectory, with net sales increasing from 106.03 crore in March 2024 to 147.66 crore in March 2025, and total operating income matching this growth at 147.66 crore. The operating profit (PBDIT) rose to 34.84 crore, while profit before tax reached 33.08 crore, culminating in a profit after tax of 25.34 crore. The company's raw material costs also increased significantly, reflecting the scale of operations, with total expenditure rising to 118.84 crore. On the balance sheet, total assets and total liabilities both stood at 151.65 crore in March 2025, indicating a balanced financial position. Cash flow from operating activities decreased to 7.00 crore, while investing activities showed a cash outflow of -3.00 crore, highlighting the company's investment strategy amidst its growth.

View full answer

When is the next results date for Sika Interplant Systems Ltd?

04-Feb-2026

The next results date for Sika Interplant Systems Ltd is 11 February 2026.

The next results date for Sika Interplant Systems Ltd is scheduled for 11 February 2026.

View full answer

Are Sika Interplant Systems Ltd latest results good or bad?

12-Feb-2026

Sika Interplant Systems Ltd's latest results show strong year-on-year growth, with revenue up 55.17% and net profit up 44.43%. However, there are concerns due to a sequential decline in both revenue and profit, indicating potential volatility and execution challenges.

Sika Interplant Systems Ltd's latest results present a mixed picture. On one hand, the company achieved a significant year-on-year growth in both revenue and net profit for Q2 FY26, with revenue increasing by 55.17% to ₹51.58 crores and net profit rising by 44.43% to ₹8.94 crores. This indicates strong underlying demand and operational efficiency, as reflected in an improved operating margin of 20.63%, which is up 243 basis points year-on-year.<BR><BR>However, the results also show a concerning sequential decline, with revenue down 24.16% and net profit down 13.62% compared to the previous quarter. This sharp drop raises questions about order book visibility and execution consistency, which are critical in the project-driven aerospace and defence sector.<BR><BR>Overall, while the year-on-year growth is impressive and suggests a solid long-term trajectory, the quarter-on-quarter declines highlight volatility and potential execution challenges. Investors may need to weigh these factors carefully when assessing the company's performance.

View full answer

Should I buy, sell or hold Sika Interplant Systems Ltd?

03-Mar-2026

Why is Sika Interplant Systems Ltd falling/rising?

23-Mar-2026

As of 23-Mar, Sika Interplant Systems Ltd's stock price is declining, currently at 895.00, down 2.21% and trading below key moving averages. Despite strong long-term growth indicators, the stock's high valuation and lack of institutional investor interest contribute to its bearish trend.

As of 23-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 895.00, which reflects a decrease of 20.25 or 2.21%. The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of 3.07% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>In terms of broader performance, the stock has underperformed relative to the benchmark Sensex over the past week and month, with declines of 5.66% and 8.89%, respectively. The engineering sector, in which Sika operates, has also seen a decline of 4.28%, contributing to the negative sentiment surrounding the stock.<BR><BR>Investor participation appears to be waning, as evidenced by a significant drop in delivery volume, which fell by 40.93% compared to the 5-day average. This lack of investor interest may further pressure the stock price.<BR><BR>Despite the company's strong long-term growth indicators, including a healthy increase in net sales and operating profit, the stock's current valuation is considered expensive, with a Price to Book Value ratio of 12.9. This premium valuation, coupled with the fact that domestic mutual funds hold no stake in the company, suggests a lack of confidence among institutional investors, which may be influencing the stock's decline.

View full answer

Why is Sika Interplant Systems Ltd falling/rising?

24-Mar-2026

As of 24-Mar, Sika Interplant Systems Ltd's stock price is at 903.25, down 2.3 points. The stock has been declining for four consecutive days, underperforming its sector, despite strong annual returns, indicating bearish sentiment and investor caution.

As of 24-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 903.25, reflecting a change of -2.3 (-0.25%). The stock has been on a downward trend, having lost value for the last four consecutive days, with a total decline of -2.17% during this period. Additionally, the stock has underperformed its sector by -2.06% today.<BR><BR>Despite a strong performance over the past year, where it generated a return of 72.47%, the stock is currently trading lower than its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day). This suggests a bearish sentiment among investors. The stock's intraday high was Rs 934, but it did not sustain this level, indicating selling pressure.<BR><BR>Investor participation has increased, with delivery volume rising by 70.56% against the 5-day average, which could imply that some investors are taking advantage of the lower price to accumulate shares. However, the overall liquidity remains adequate for trading.<BR><BR>The company's fundamentals show healthy growth, with net sales and operating profit increasing significantly. However, the stock is considered expensive with a high Price to Book Value ratio of 13, and domestic mutual funds hold no stake in the company, which may reflect a lack of confidence at current price levels. These factors contribute to the stock's current decline.

View full answer

Why is Sika Interplant Systems Ltd falling/rising?

25-Mar-2026

As of 25-Mar, Sika Interplant Systems Ltd's stock price is 902.00, down 1.25 (-0.14%), and has declined 2.31% over the last five days. The stock is underperforming its sector and is trading below all key moving averages, indicating a bearish trend despite the company's strong long-term growth metrics.

As of 25-Mar, Sika Interplant Systems Ltd's stock price is currently at 902.00, reflecting a decrease of 1.25 (-0.14%). The stock has been on a downward trend, having fallen consecutively for the last five days, resulting in a total decline of 2.31% over that period. This underperformance is notable as it has also lagged behind the sector, underperforming by 2.68% today.<BR><BR>Despite opening with a gain of 2.2% and reaching an intraday high of Rs 929.7, the overall movement has been negative, as the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a bearish trend in the stock's performance.<BR><BR>While the company has shown healthy long-term growth with net sales increasing at an annual rate of 27.62% and operating profit at 33.62%, the stock's valuation appears to be a concern. With a return on equity (ROE) of 24.9 and a price-to-book value of 13, the stock is considered very expensive compared to its peers. Additionally, despite generating a return of 44.60% over the past year, the stock's profits have risen by 48.7%, leading to a PEG ratio of 1.1, which suggests that the stock may be overvalued.<BR><BR>Furthermore, the lack of investment from domestic mutual funds, which hold 0% of the company, may indicate a lack of confidence in the stock's current price or business outlook. This combination of factors contributes to the stock's recent decline, overshadowing its previous positive performance and growth metrics.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 24.9, it has a Very Expensive valuation with a 13 Price to Book Value

  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 44.60%, its profits have risen by 48.7% ; the PEG ratio of the company is 1.1
2

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Aerospace & Defense

stock-summary
Market cap

INR 1,959 Cr (Small Cap)

stock-summary
P/E

52.00

stock-summary
Industry P/E

28

stock-summary
Dividend Yield

0.27%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

24.88%

stock-summary
Price to Book

12.99

Revenue and Profits:
Net Sales:
50 Cr
(Quarterly Results - Dec 2025)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.27%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-29.36%
0%
-29.36%
1 Year
44.6%
0.38%
44.98%
2 Years
214.99%
3.59%
218.58%
3 Years
676.38%
14.27%
690.65%
4 Years
603.81%
12.54%
616.35%
5 Years
1453.3%
39.30%
1492.6%

Latest dividend: 2.4 per share ex-dividend date: Jul-02-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Sika Interplant Systems Ltd Falls 0.75%: 4 Key Factors Driving the Week’s Volatility

Announcements stock-summary

Closure of Trading Window

25-Mar-2026 | Source : BSE

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Newspaper Publication

11-Mar-2026 | Source : BSE

Special Window for Transfer and Dematerialization of physical Shares

Reply To Discrepancies In Financial Results Under Regulation 33 Of SEBI (LODR) Regulations 2015

10-Mar-2026 | Source : BSE

Reply to Discrepancies in Financial Results under Regulation 33 of SEBI(LODR)2015

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sika Interplant Systems Ltd has declared 120% dividend, ex-date: 02 Jul 25

stock-summary
SPLITS

Sika Interplant Systems Ltd has announced 2:10 stock split, ex-date: 17 Mar 25

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
27.62%
EBIT Growth (5y)
33.62%
EBIT to Interest (avg)
23.14
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.45
Tax Ratio
23.60%
Dividend Payout Ratio
21.90%
Pledged Shares
0
Institutional Holding
3.18%
ROCE (avg)
35.60%
ROE (avg)
20.04%

Valuation key factors

Factor
Value
P/E Ratio
52
Industry P/E
28
Price to Book Value
12.97
EV to EBIT
45.20
EV to EBITDA
44.04
EV to Capital Employed
16.25
EV to Sales
8.71
PEG Ratio
1.07
Dividend Yield
0.27%
ROCE (Latest)
35.95%
ROE (Latest)
24.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (3.14%)

Promoter with highest holding

Ultraweld Engineers Llp (70.1%)

Highest Public shareholder

Rimo Capital Fund Lp (2.8%)

Individual Investors Holdings

20.33%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.46% vs -24.16% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 6.15% vs -13.62% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.31",
          "val2": "51.58",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.59",
          "val2": "10.64",
          "chgp": "8.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.13",
          "chgp": "-30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.49",
          "val2": "8.94",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.04%",
          "val2": "20.63%",
          "chgp": "2.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 87.86% vs 48.46% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 76.31% vs 26.02% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "119.59",
          "val2": "63.66",
          "chgp": "87.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.14",
          "val2": "13.03",
          "chgp": "77.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.09",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.44",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.13",
          "val2": "10.85",
          "chgp": "76.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.35%",
          "val2": "20.47%",
          "chgp": "-1.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 67.16% vs 47.56% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 59.00% vs 34.83% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "169.90",
          "val2": "101.64",
          "chgp": "67.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.73",
          "val2": "20.86",
          "chgp": "66.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.11",
          "chgp": "227.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.44",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.62",
          "val2": "18.00",
          "chgp": "59.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.44%",
          "val2": "20.52%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 39.26% vs 76.69% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 30.28% vs 118.79% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "147.66",
          "val2": "106.03",
          "chgp": "39.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.82",
          "val2": "19.90",
          "chgp": "44.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.20",
          "chgp": "30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.44",
          "val2": "1.17",
          "chgp": "-137.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.34",
          "val2": "19.45",
          "chgp": "30.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.52%",
          "val2": "18.77%",
          "chgp": "0.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
50.31
51.58
-2.46%
Operating Profit (PBDIT) excl Other Income
11.59
10.64
8.93%
Interest
0.09
0.13
-30.77%
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.49
8.94
6.15%
Operating Profit Margin (Excl OI)
23.04%
20.63%
2.41%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -2.46% vs -24.16% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 6.15% vs -13.62% in Sep 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
119.59
63.66
87.86%
Operating Profit (PBDIT) excl Other Income
23.14
13.03
77.59%
Interest
0.27
0.09
200.00%
Exceptional Items
0.00
-0.44
100.00%
Consolidate Net Profit
19.13
10.85
76.31%
Operating Profit Margin (Excl OI)
19.35%
20.47%
-1.12%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 87.86% vs 48.46% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 76.31% vs 26.02% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
169.90
101.64
67.16%
Operating Profit (PBDIT) excl Other Income
34.73
20.86
66.49%
Interest
0.36
0.11
227.27%
Exceptional Items
0.00
-0.44
100.00%
Consolidate Net Profit
28.62
18.00
59.00%
Operating Profit Margin (Excl OI)
20.44%
20.52%
-0.08%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 67.16% vs 47.56% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 59.00% vs 34.83% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
147.66
106.03
39.26%
Operating Profit (PBDIT) excl Other Income
28.82
19.90
44.82%
Interest
0.26
0.20
30.00%
Exceptional Items
-0.44
1.17
-137.61%
Consolidate Net Profit
25.34
19.45
30.28%
Operating Profit Margin (Excl OI)
19.52%
18.77%
0.75%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 39.26% vs 76.69% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 30.28% vs 118.79% in Mar 2024

stock-summaryCompany CV
About Sika Interplant Systems Ltd stock-summary
stock-summary
Sika Interplant Systems Ltd
Small Cap
Aerospace & Defense
Sika Interplant Systems Limited, an engineering driven company focused on the Aerospace, Defence & Space (A&D) and Automotive sectors in India was incorporated in 1985. The Company is actively involved in four main areas, namely, engineering (design and development); manufacturing, assembly and testing; projects and systems integration; and maintenance, repair and overhaul (MRO).
Company Coordinates stock-summary
Company Details
No 3 Gangadhara Chetty Road , Bangalore Karnataka : 560042
stock-summary
Tel: 91-080-25599144/25599086
stock-summary
comp.sec@sikaglobal.com
Registrar Details
Integrated Enterprises (India) Ltd , 30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram, Bangalore